Right at Home’s Brady Schwab is looking to a partnership with a tech startup to provide a higher level of care for clients and introduce home care to a broader segment of the population.

A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Q4 2024 Earnings Call Transcript February 27, 2025 Verona Pharma plc misses on earnings expectations. Reported EPS is $-0.4 ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

4 BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy that could potentially address unmet needs by inserting a functional copy of the CFTR gene in the DNA of airway ...

Researchers at the La Jolla Institute for Immunology (LJI) have developed a specific drug "cocktail" that promises to curb severe asthma flare-ups, potentially decreasing the reliance on inhalers ...

But now, scientists may have found a way to stop the condition in its tracks - and possibly even reduce the need for inhalers for day-to-day symptom management. A team at La Jolla Institute for ...